SSTI & DFI Flashcards

1
Q

How do non-purulent SSTIs present?

A
  • tender
  • erythema
  • swelling
  • warm to touch
  • orange peel-like skin
  • NO PUS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are non-purulent SSTIs further classified?

A
  • mild –> no systemic signs of infection
  • moderate –> systemic signs like fever & chills
  • severe –> meets SIRS criteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the SIRS criteria?

A
  • Temp > 38C or < 36C
  • HR > 90 bpm
  • RR > 24 bpm
  • WBC > 12K or < 4K

Must meet two of these to be SIRS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the causative pathogens for non-purulent SSTIs?

A
  • streptococcus spp
  • MRSA

  • group A - strep pyogenes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the treatment options for a mild, non-purulent SSTI?

Duration: 5 days

A

Oral abx

  • pen VK
  • cephalosporin
  • dicloxacillin
  • clindamycin

pick one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the treatment options for a moderate, non-purulent SSTI?

Duration: 5 days

A

IV abx

  • PCN
  • ceftriaxone
  • cefazolin
  • clindamycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the treatment options for a severe, non-purulent SSTI?

Duration: 5 days

A

Emergent surgical inspection/debridement followed by empiric abx

  • vancomycin + piperacillin/tazobactam

Narrow based on culture and sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is an abscess?

A

collection of pus within the dermis and deeper skin tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a furuncle?

boil

A

small abscess that involves a hair follicle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are carbuncles?

A

infection involving several adjacent follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does a purulent SSTI present?

A
  • tender
  • red nodules
  • erythema
  • warm to touch
  • PUS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When are cultures recommended for purulent SSTIs?

A

Wound cultures are recommended for all abscesses, carbuncles, and patients with systemic signs of infection regardless of severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are purulent SSTIs classified?

A
  • mild –> no systemic signs of infection
  • moderate –> systemic signs of infection
  • severe –> SIRS

same as non-purulent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the causative pathogens for purulent SSTIs?

A
  • MRSA
  • MSSA
  • streptococcus spp
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the treatment options for a mild, purulent SSTI?

A
  • incision and drainage (I & D)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the empiric abx used for moderate, purulent SSTI?

A
  • TMP/SMX or
  • doxycycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which antibiotics are used for targeted therapy for a moderate, purulent SSTI?

A
  • If MRSA –> TMP/SMX, doxycycline
  • If MSSA –> cephalexin, dicloxacillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which antibiotics are used for empiric therapy for a severe, purulent SSTI?

A
  • vancomycin or
  • daptomycin or
  • linezolid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which antibiotic are used for targeted therapy for a severe, purulent SSTI?

A
  • If MRSA –> vanc or dapto or linezolid
  • If MSSA –> nafcillin or cefazolin or clindamycin
20
Q

What is necrotizing fasciitis characterized as?

A

severe, non-purulent SSTI

Medical emergency associated with high morbidity and mortality

21
Q

What are the causative pathogens for necrotizing fasciitis?

A

streptococcus spp

vibrio vulnificus, peptostreptococcus spp., CA-MRSA, aeromonas hydrophila, clostridium perfringens

22
Q

What is the treatment process for necrotizing fasciitis?

A
  1. emergency surgical inspection/debridement
  2. empiric abx –> vancomycin + piperacillin/tazobactam
  3. cultures & susceptibility
  4. Targeted abx
    - If strep pyogenes –> pcn + clindamycin
    - If polymicrobial –> vancomycin + piperacillin/tazobactam
23
Q

How is duration of abx determined for necrotizing fasciitis?

A
  • further debridement is no longer necessary
  • patient has improved clinically
  • fever has been absent for 48-72 hours
24
Q

What is impetigo and how does it present?

A
  • Impetigo is a highly contagious superficial skin infection caused by skin abrasions
  • small, painless, fluid filled vesicles that can lead to thick golden crusts
25
Q

What is the treatment option for a case of impetigo with few lesions?

A
  • topical mupirocin for 5 days
26
Q

What are the treatment options for an impetigo outbreak with many lesions?

oral abx for 7 days

A
  • cephalexin or dicloxacillin
  • if strep only –> pcn
  • if allergies or MRSA –> doxycycline, clindamycin, or TMP/SMX
27
Q

What is the duration of therapy for abx for an established infection from an animal or human bite?

28
Q

What is the duration of therapy for preemptively addressing an animal/human bite?

has been bit, but not necessarily infected

29
Q

What is the DOC for animal/human bites?

A

Amox/clav

  • 7-14 days for established infections
  • 3-5 days for preemptive tx
30
Q

What alternative agents can be used for animal/human bites?

A
  • 2nd or 3rd gen cephalosporins + anaerobic coverage
  • If B-lactam allergy –> cipro/levo + anaerobic coverage OR moxifloxacin alone

Vaccines –> Tdap if due +/- rabies

31
Q

What are common causative pathogens for an infected ulcer?

A
  • staph aureus
  • group streptococci
32
Q

What are MRSA risk factors for a patient with a DFI?

A
  • previous MRSA infection w/in the past year
  • local MRSA prevalence >30-50%
  • recent hospitalization
  • failed non-MRSA antibiotics

Exam Q: add on MRSA coverage for DFI if patient is in Indianapolis

33
Q

What are the risk factors for pseudomonas for patients with a DFI?

A
  • history of pseudomonas infection
  • soaking feet in tap water
  • warm climate
  • severe infection
  • failed non-pseudomonal antibiotics
34
Q

What are the components to managing a DFI?

A
  • surgical intervention
  • glycemic control
  • antibiotics
35
Q

What does an antibiotic regimen for a mild DFI need to cover?

A
  • MSSA
  • group strep
36
Q

What are the treatment options for a mild DFI?

needs to cover MSSA and group strep

A
  • dicloxacillin or
  • cephalexin or
  • clindamycin

duration of 1-2 weeks

37
Q

What drug should you switch to if a patient with a mild DFI has a history of recent abx use?

A
  • amox/clav or
  • levofloxacin or
  • moxifloxacin

duration of 1-2 weeks

38
Q

What are the treatment options for a mild DFI in a patient with MRSA risk factors?

  • previous MRSA infection w/in past year
  • local MRSA prevalence >30-50%
  • recent hospitalization
  • failed non-MRSA abx
A
  • TMP/SMX or
  • doxycycline
39
Q

Which organisms does an abx regimen for a moderate DFI need to cover?

A
  • MSSA
  • group strep
  • enterobacterales
  • anaerobes
40
Q

What are the treatment options for a moderate DFI?

A
  • moxifloxacin
  • amox/clav
  • ciprofloxacin + clindamycin
  • levofloxacin + clindamycin

duration 2-3 weeks

41
Q

What drugs should be used for a moderate DFI in a patient with pseudomonal risk factors?

A
  • ciprofloxacin + clindamycin
  • levofloxacin + clindamycin

  • could maybe switch clinda for metronidazole if using levofloxacin
42
Q

Which drugs should be added onto the treatment regimen if the patient has a moderate DFI with MRSA risk factors?

A
  • linezolid
  • vancomycin

maybe doxycycline or TMP/SMX

43
Q

Which organisms need to be covered when treating a severe DFI?

A
  • MSSA
  • group strep
  • enterbacterales
  • anaerobes
  • pseudomonas
44
Q

What are the treatment options for a patient with a severe DFI?

A
  • piperacillin/tazobactam
  • cefepime + clindamycin
  • cefepime + metronidazole

  • duration of 2-3 weeks
  • carbapenems reserved for only when necessary (don’t want to develop resistance)
45
Q

Which drugs can be added on to a treatment regimen for severe DFI if the patient has MRSA risk factors?

A
  • vancomycin or
  • linezolid or
  • daptomycin